Quarterly Results

  • Company Name :
ERIS Lifesciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 540596
  • NSE Symbol:
  • ERIS
  • P/E(TTM):
  • 142.45
  • ISIN Demat:
  • INE406M01024
  • Div & Yield%:
  • 0.44
  • EPS(TTM):
  • 11.77
  • Book Value(₹):
  • 184.64
  • Market Cap(₹Cr.):
  • 22,836.43
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars June 2025 ( Cr)March 2025 ( Cr)December 2024 ( Cr)
Gross Sales 567.90 395.71 390.00
Excise Duty 0.00 0.00 0.00
Net Sales 567.90 395.71 390.00
Other Operating Income 10.74 9.06 9.73
Other Income 22.68 16.75 7.79
Total Income 601.32 421.52 407.52
Total Expenditure 362.32 283.80 300.16
PBIDT 239.00 137.72 107.36
Interest 45.14 53.16 54.65
PBDT 193.86 84.56 52.71
Depreciation 37.60 43.38 46.68
Tax 27.17 8.51 0.00
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 29.10 2.20 4.25
Reported Profit After Tax 99.99 30.47 1.78
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 99.99 30.47 1.78
EPS (Unit Curr.) 7.34 2.24 0.13
EPS (Adj) (Unit Curr.) 7.34 2.24 0.13
Calculated EPS (Unit Curr.) 7.34 2.24 0.13
Calculated EPS (Adj) (Unit Curr.) 7.34 2.24 0.13
Calculated EPS (Ann.) (Unit Curr.) 29.37 8.95 0.52
Calculated EPS (Adj) (Ann.) (Unit Curr.) 29.37 8.95 0.52
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 735.00
Equity 13.62 13.62 13.61
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 42.08 34.80 27.53
PBDTM(%) 34.14 21.37 13.52
PATM(%) 17.61 7.70 0.46